In this episode of the Cardiovascular Matters podcast, host Dr. Craig Walker discusses the growing problem of obesity in America and revolutionary new medication options that are helping people safely and effectively lose weight. Dr. Walker explains how obesity increases the risk of heart disease, diabetes and other serious health conditions. He then outlines several new classes of drugs, including GLP-1 agonists, that work to control hunger and blood sugar levels while promoting weight loss. Medical device sales veteran and patient Terry Roberts shares his own positive experience using these medications. Listeners will learn about treatment options and get insight into safely and successfully managing their weight.


Key points:

• The health risks of obesity like heart disease, diabetes and joint problems
• New classes of drugs for weight loss like GLP-1 agonists
• How the drugs work to control hunger, blood sugar and promote weight loss
• Positive results seen in weight loss and cardiovascular outcomes
• Terry Roberts shares his success with the medication plan

Chapter Markers:
0:00-5:00 - Introduction and overview of topic
5:00-10:00 - Health risks of obesity like heart disease and diabetes
10:00-15:00 - Introduction to new classes of weight loss drugs like GLP-1 agonists
15:00-20:00 - How the drugs work to control hunger and blood sugar
20:00-25:00 - Positive results seen in weight loss and cardiovascular outcomes
25:00-30:00 - Terry Roberts shares his success with the medication plan
30:00-35:00 - Q&A and call to action for listeners considering treatment

For more information, visit:
Facebook Page: facebook.com/profile.php?id=61558432490919
www.cardio.com